Design of INFORMUS, a pragmatic, randomized, double-blind, placebo-controlled study of cardiovascular outcomes with the extended-release, fixed-dose combination of naltrexone and bupropion

Obesity Pillars · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles